Cargando…

E-cadherin: A potential biomarker of colorectal cancer prognosis

Colorectal cancer (CRC) is a common and lethal disease. It is the third most common type of cancer in the world, behind lung and breast cancer, with almost 1.4 million new cases diagnosed in 2012. The risk of developing CRC is influenced by environmental and genetic factors. Adenocarcinomas comprise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christou, Niki, Perraud, Aurélie, Blondy, Sabrina, Jauberteau, Marie-Odile, Battu, Serge, Mathonnet, Muriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452924/ https://www.ncbi.nlm.nih.gov/pubmed/28588719 http://dx.doi.org/10.3892/ol.2017.6063

Ejemplares similares

Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
por: Blondy, Sabrina, et al.
Publicado: (2020)

Neurotrophins and their involvement in digestive cancers
por: Blondy, Sabrina, et al.
Publicado: (2019)

Neurotensin pathway in digestive cancers and clinical applications: an overview
por: Christou, Niki, et al.
Publicado: (2020)

Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer
por: Mazouffre, Clément, et al.
Publicado: (2017)

5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
por: Blondy, Sabrina, et al.
Publicado: (2020)

Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness
por: Blondy, Sabrina, et al.
Publicado: (2022)

Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival
por: Akil, Hussein, et al.
Publicado: (2011)

Intraperitoneal Chemotherapy for Peritoneal Metastases: Technical Innovations, Preclinical and Clinical Advances and Future Perspectives
por: Christou, Niki, et al.
Publicado: (2021)

The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials
por: Hervieu, Céline, et al.
Publicado: (2021)

A Label-Free Cell Sorting Approach to Highlight the Impact of Intratumoral Cellular Heterogeneity and Cancer Stem Cells on Response to Therapies
por: Hervieu, Céline, et al.
Publicado: (2022)

Personalized Therapy and Liquid Biopsy—A Focus on Colorectal Cancer
por: Christou, Niki, et al.
Publicado: (2021)

Autophagy and Extracellular Vesicles in Colorectal Cancer: Interactions and Common Actors?
por: Auger, Clément, et al.
Publicado: (2021)

Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases
por: Carpenet, Helene, et al.
Publicado: (2017)

TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells
por: Pinet, Sandra, et al.
Publicado: (2016)

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
por: Tarhini, Zeinab, et al.
Publicado: (2022)

SCO-spondin oligopeptide inhibits angiogenesis in glioblastoma
por: Bibes, Romain, et al.
Publicado: (2017)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
por: Christou, Niki, et al.
Publicado: (2019)

Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review
por: Taibi, Abdelkader, et al.
Publicado: (2019)

KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness
por: Cheray, Mathilde, et al.
Publicado: (2016)

Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome
por: Christou, Niki, et al.
Publicado: (2018)

Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept
por: Bounaix Morand du Puch, Christophe, et al.
Publicado: (2021)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

Snail inhibits metastasis via regulation of E‑cadherin and is associated with prognosis in colorectal cancer
por: Wang, Weimin, et al.
Publicado: (2023)

E-cadherin and Snail Immunoexpression in Colorectal Adenocarcinomas
por: AL KHATIB, AM, et al.
Publicado: (2019)

p75 neurotrophin receptor and pro-BDNF promote cell survival and migration in clear cell renal cell carcinoma
por: De la Cruz-Morcillo, Miguel A., et al.
Publicado: (2016)

ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme®
por: Mathonnet, Muriel, et al.
Publicado: (2021)

Recycling of E-Cadherin: A Potential Mechanism for Regulating Cadherin Dynamics
por: Le, Tam Luan, et al.
Publicado: (1999)

Extracellular Vesicle Measurements with Nanoparticle Tracking Analysis: A Different Appreciation of Up and Down Secretion
por: Auger, Clément, et al.
Publicado: (2022)

Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma
por: Rajkumar, Sharmilla Devi, et al.
Publicado: (2021)

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts
por: Moatassim-Billah, Siham, et al.
Publicado: (2016)

Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
por: Duluc, Camille, et al.
Publicado: (2015)

E-Cadherin as a diagnostic biomarker in breast cancer
por: Singhai, Rajeev, et al.
Publicado: (2011)

Autophagy inhibition reinforces stemness together with exit from dormancy of polydisperse glioblastoma stem cells
por: Brunel, Aude, et al.
Publicado: (2021)

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

Blood serum levels of E-cadherin in patients with colorectal cancer
por: Cepowicz, Dariusz, et al.
Publicado: (2017)

Downregulated E-Cadherin Expression Indicates Worse Prognosis in Asian Patients with Colorectal Cancer: Evidence from Meta-Analysis
por: He, Xin, et al.
Publicado: (2013)

Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer
por: NAKAMOTO, KENTARO, et al.
Publicado: (2013)

Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy
por: Ali, Hamad, et al.
Publicado: (2022)

Slug, Twist, and E-Cadherin as Immunohistochemical Biomarkers in Meningeal Tumors
por: Nagaishi, Masaya, et al.
Publicado: (2012)

Squalene Epoxidase Correlates E-Cadherin Expression and Overall Survival in Colorectal Cancer Patients: The Impact on Prognosis and Correlation to Clinicopathologic Features
por: Kim, Joo Heon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ron5tt3i7qgd6oopaikcc69caj